U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula 2C7H5O3.2C5H14NO.Mg.O4S
Molecular Weight 602.935
Optical Activity NONE
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SALCOLEX ANHYDROUS

SMILES

[Mg++].[O-]S([O-])(=O)=O.C[N+](C)(C)CCO.C[N+](C)(C)CCO.OC1=C(C=CC=C1)C([O-])=O.OC2=C(C=CC=C2)C([O-])=O

InChI

InChIKey=JFFTWGWKXDKILV-UHFFFAOYSA-J
InChI=1S/2C7H6O3.2C5H14NO.Mg.H2O4S/c2*8-6-4-2-1-3-5(6)7(9)10;2*1-6(2,3)4-5-7;;1-5(2,3)4/h2*1-4,8H,(H,9,10);2*7H,4-5H2,1-3H3;;(H2,1,2,3,4)/q;;2*+1;+2;/p-4

HIDE SMILES / InChI

Molecular Formula C7H6O3
Molecular Weight 138.1207
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula O4S
Molecular Weight 96.063
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Mg
Molecular Weight 24.305
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C5H13NO
Molecular Weight 103.1628
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Audax

Approved Use

Audax is used in combination with magnesium salicylate as part of anti-pain medication. It is used to relieve pain and discomfort in the mouth caused by ulcers, sores or dentures/ braces. It is also used for relief from pain, swelling and stiffness caused due to arthritis or shoulder problems.

Sample Use Guides

In Vivo Use Guide
Oral Pain and fever Adult: 435-870 mg every 4 hr when required. Oral Rheumatic disorders Adult: 4.8-7.2 g daily in divided doses. Buccal Mouth lesions Adult: Apply 8.7% gel on affected area.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:38:50 GMT 2025
Edited
by admin
on Mon Mar 31 19:38:50 GMT 2025
Record UNII
7UP781YBR6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ETHANAMINIUM, 2-HYDROXY-N,N,N-TRIMETHYL-, 2-HYDROXYBENZOATE (SALT), COMPD. WITH MAGNESIUM SULFATE (2:1)
Preferred Name English
SALCOLEX ANHYDROUS
Common Name English
SALICYLATE (SALT) COMPOUND WITH MAGNESIUM SULFATE (2:1)
Common Name English
SALCOLEX, ANHYDROUS
Common Name English
ETHANAMINIUM, 2-HYDROXY-N,N,N-TRIMETHYL-, 2-HYDROXYBENZOATE, COMPD. WITH MAGNESIUM SULFATE (2:2:1:1)
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID80202545
Created by admin on Mon Mar 31 19:38:50 GMT 2025 , Edited by admin on Mon Mar 31 19:38:50 GMT 2025
PRIMARY
CAS
54194-00-2
Created by admin on Mon Mar 31 19:38:50 GMT 2025 , Edited by admin on Mon Mar 31 19:38:50 GMT 2025
PRIMARY
FDA UNII
7UP781YBR6
Created by admin on Mon Mar 31 19:38:50 GMT 2025 , Edited by admin on Mon Mar 31 19:38:50 GMT 2025
PRIMARY
PUBCHEM
70697657
Created by admin on Mon Mar 31 19:38:50 GMT 2025 , Edited by admin on Mon Mar 31 19:38:50 GMT 2025
PRIMARY
SMS_ID
100000080524
Created by admin on Mon Mar 31 19:38:50 GMT 2025 , Edited by admin on Mon Mar 31 19:38:50 GMT 2025
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE